<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:video="http://www.google.com/schemas/sitemap-video/1.1" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
    <url>
    <loc>https://www.biomedicalcue.it/vaccino-a-mrna-contro-il-melanoma-cosa-dicono-davvero-i-risultati-di-fase-3/</loc>
    <lastmod>2026-08-19T14:43:05+00:00</lastmod>
    <priority>0.5</priority>
            <news:news>
    <news:publication>
        <news:name>Biomed CuE</news:name>
        <news:language>it</news:language>
    </news:publication>
    <news:title>Vaccino a mRNA contro il melanoma? Cosa dicono davvero i risultati di fase 3</news:title>
    <news:publication_date>2026-08-19T14:33:35+00:00</news:publication_date>
    <news:keywords>Innovazione,Patologie,Biomedicalcue</news:keywords>
</news:news></url>
    <url>
    <loc>https://www.biomedicalcue.it/malaria-il-genoma-svela-resistenze-che-la-clinica-non-vede/</loc>
    <lastmod>2026-08-19T11:23:05+00:00</lastmod>
    <priority>0.5</priority>
            <news:news>
    <news:publication>
        <news:name>Biomed CuE</news:name>
        <news:language>it</news:language>
    </news:publication>
    <news:title>Malaria, il genoma svela resistenze che la clinica non vede</news:title>
    <news:publication_date>2026-08-19T11:17:58+00:00</news:publication_date>
    <news:keywords>Patologie,Biomedicalcue</news:keywords>
</news:news></url>
</urlset>
